UroGen Pharma Ltd.
Immunomodulating treatments of body cavities

Last updated:

Abstract:

Described herein are compositions and methods for treating cancer of a body cavity, specifically urinary tract cancer, by way of a combination of at least two immunomodulatory agents, wherein one or more of the therapeutic agents are embedded in, and slowly released from, a biocompatible hydrogel composition.

Status:
Grant
Type:

Utility

Filling date:

11 Mar 2019

Issue date:

1 Sep 2020